Lagoda Investment Management as of Sept. 30, 2015
Portfolio Holdings for Lagoda Investment Management
Lagoda Investment Management holds 32 positions in its portfolio as reported in the September 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Regeneron Pharmaceuticals (REGN) | 13.5 | $46M | 100k | 465.14 | |
Novo Nordisk A/S (NVO) | 10.7 | $37M | 673k | 54.24 | |
Alexion Pharmaceuticals | 7.6 | $26M | 167k | 156.39 | |
Seattle Genetics | 7.2 | $25M | 637k | 38.56 | |
Renaissance Re Holdings Ltd Cmn (RNR) | 6.7 | $23M | 217k | 106.32 | |
Berkshire Hathaway (BRK.A) | 6.5 | $22M | 114.00 | 195236.84 | |
Merrimack Pharmaceuticals In | 5.9 | $20M | 2.4M | 8.51 | |
Senomyx | 5.5 | $19M | 4.2M | 4.46 | |
Alphabet Inc Class C cs (GOOG) | 4.9 | $17M | 28k | 608.41 | |
Monsanto Company | 4.4 | $15M | 177k | 85.34 | |
Intrexon | 3.9 | $13M | 418k | 31.80 | |
Digimarc Corporation (DMRC) | 3.4 | $12M | 384k | 30.55 | |
Corning Incorporated (GLW) | 3.2 | $11M | 638k | 17.12 | |
Ptc (PTC) | 2.9 | $10M | 314k | 31.74 | |
Allison Transmission Hldngs I (ALSN) | 2.7 | $9.3M | 347k | 26.69 | |
Alphabet Inc Class A cs (GOOGL) | 2.4 | $8.3M | 13k | 638.39 | |
Johnson & Johnson (JNJ) | 2.1 | $7.1M | 76k | 93.35 | |
Ubiquiti Networks | 1.3 | $4.6M | 135k | 33.89 | |
Berkshire Hathaway (BRK.B) | 1.3 | $4.6M | 35k | 130.39 | |
Valeant Pharmaceuticals Int | 1.2 | $4.3M | 24k | 178.40 | |
Enstar Group (ESGR) | 1.1 | $3.8M | 25k | 150.00 | |
MasterCard Incorporated (MA) | 0.9 | $3.0M | 34k | 90.12 | |
Nidec Corporation (NJDCY) | 0.4 | $1.3M | 77k | 17.33 | |
Alleghany Corporation | 0.1 | $300k | 640.00 | 468.75 | |
Randgold Resources | 0.1 | $266k | 4.5k | 59.11 | |
Exxon Mobil Corporation (XOM) | 0.0 | $53k | 715.00 | 74.13 | |
ConocoPhillips (COP) | 0.0 | $81k | 1.7k | 47.68 | |
Abbott Laboratories (ABT) | 0.0 | $26k | 640.00 | 40.62 | |
Pfizer (PFE) | 0.0 | $51k | 1.6k | 31.54 | |
Phillips 66 (PSX) | 0.0 | $19k | 247.00 | 76.92 | |
Abbvie (ABBV) | 0.0 | $27k | 491.00 | 54.99 | |
GlaxoSmithKline | 0.0 | $9.0k | 239.00 | 37.66 |